3rd Annual Inhalation & Respiratory Drug Delivery USA Congress
About This Event
Join us to hear about the latest industry innovations at Oxford Global's Inhalation and Respiratory Drug Delivery USA Congress, 17 - 18 March 2020 in San Diego.
Over 300 delegates from the inhalation, formulation and drug delivery industry representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and research institutions.
Over 20 presentations and case studies focussing on the emerging therapies and key issues in inhalation and respiratory drug delivery as well as the latest developments in medical devices and digital health products.
Including 2 interactive streams:
- Development and Formulation of Inhaled Therapies
- Inhalation Devices and Analytics
This event is co-located with the 3rd Annual Formulation and Drug Delivery USA Congress
For more information, please contact [email protected]
Go Social: Join our Formulation and Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress and join the conversation at #FDDUS19
2020 Live Webinar
'The Design And Development Of A Connected Inhalation System To Help With Monitoring And Patient Adherence'
Hosted by Paul Upham, Head, Smart Devices, Genentech
Wed, Jan 15, 2020 4:30 PM - 5:30 PM GMT
Register for Free: https://bit.ly/2kK3BqB
URLs:
Tickets: https://go.evvnt.com/525538-2?pid=154
Brochure: https://go.evvnt.com/525538-3?pid=154
Price:
Registration Available from: USD 720.00
Time: 07:30 - 17:00
Speakers: Christy Cappelletti, Director, Clinical Development, AstraZeneca, Yaping Zhu, Executive Director, Device Development & Inhalation Development, Sandoz, George Cusatis, Associate Director, Device & Digital Health, Merck, Samir Shah, Associate Director, Respiratory and Combination Regulatory Affairs, Teva, Paul Upham, Head, Smart Devices, Genentech, Larry Brown, Chief Scientific Officer & Executive Vice President, Noveome, Carlos Schuler, Chief Operating and Technical Officer, InCarda Therapeutics, Stephen Pham, Vice President Product Development, Avalyn Pharma